File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications

TitleBiliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
Authors
Keywordsbiliary fibrosis
cholangiopathy
etiology
mechanism
therapeutic strategy
Issue Date1-Jul-2024
PublisherDe Gruyter
Citation
Medical Review, 2024, v. 4, n. 4, p. 326-365 How to Cite?
Abstract

Fibrosis resulting from pathological repair secondary to recurrent or persistent tissue damage often leads to organ failure and mortality. Biliary fibrosis is a crucial but easily neglected pathological feature in hepatobiliary disorders, which may promote the development and progression of benign and malignant biliary diseases through pathological healing mechanisms secondary to biliary tract injuries. Elucidating the etiology and pathogenesis of biliary fibrosis is beneficial to the prevention and treatment of biliary diseases. In this review, we emphasized the importance of biliary fibrosis in cholangiopathies and summarized the clinical manifestations, epidemiology, and aberrant cellular composition involving the biliary ductules, cholangiocytes, immune system, fibroblasts, and the microbiome. We also focused on pivotal signaling pathways and offered insights into ongoing clinical trials and proposing a strategic approach for managing biliary fibrosis-related cholangiopathies. This review will offer a comprehensive perspective on biliary fibrosis and provide an important reference for future mechanism research and innovative therapy to prevent or reverse fibrosis.


Persistent Identifierhttp://hdl.handle.net/10722/345751

 

DC FieldValueLanguage
dc.contributor.authorZhao, Jinyu-
dc.contributor.authorYue, Ping-
dc.contributor.authorMi, Ningning-
dc.contributor.authorLi, Matu-
dc.contributor.authorFu, Wenkang-
dc.contributor.authorZhang, Xianzhuo-
dc.contributor.authorGao, Long-
dc.contributor.authorBai, Mingzhen-
dc.contributor.authorTian, Liang-
dc.contributor.authorJiang, Ningzu-
dc.contributor.authorLu, Yawen-
dc.contributor.authorMa, Haidong-
dc.contributor.authorDong, Chunlu-
dc.contributor.authorZhang, Yong-
dc.contributor.authorZhang, Hengwei-
dc.contributor.authorZhang, Jinduo-
dc.contributor.authorRen, Yanxian-
dc.contributor.authorSuzuki, Azumi-
dc.contributor.authorWong, Peng F-
dc.contributor.authorTanaka, Kiyohito-
dc.contributor.authorRerknimitr, Rungsun-
dc.contributor.authorJunger, Henrik H-
dc.contributor.authorCheung, Tan T-
dc.contributor.authorMelloul, Emmanuel-
dc.contributor.authorDemartines, Nicolas-
dc.contributor.authorLeung, Joseph W-
dc.contributor.authorYao, Jia-
dc.contributor.authorYuan, Jinqiu-
dc.contributor.authorLin, Yanyan-
dc.contributor.authorSchlitt, Hans J-
dc.contributor.authorMeng, Wenbo-
dc.date.accessioned2024-08-27T09:10:56Z-
dc.date.available2024-08-27T09:10:56Z-
dc.date.issued2024-07-01-
dc.identifier.citationMedical Review, 2024, v. 4, n. 4, p. 326-365-
dc.identifier.urihttp://hdl.handle.net/10722/345751-
dc.description.abstract<p>Fibrosis resulting from pathological repair secondary to recurrent or persistent tissue damage often leads to organ failure and mortality. Biliary fibrosis is a crucial but easily neglected pathological feature in hepatobiliary disorders, which may promote the development and progression of benign and malignant biliary diseases through pathological healing mechanisms secondary to biliary tract injuries. Elucidating the etiology and pathogenesis of biliary fibrosis is beneficial to the prevention and treatment of biliary diseases. In this review, we emphasized the importance of biliary fibrosis in cholangiopathies and summarized the clinical manifestations, epidemiology, and aberrant cellular composition involving the biliary ductules, cholangiocytes, immune system, fibroblasts, and the microbiome. We also focused on pivotal signaling pathways and offered insights into ongoing clinical trials and proposing a strategic approach for managing biliary fibrosis-related cholangiopathies. This review will offer a comprehensive perspective on biliary fibrosis and provide an important reference for future mechanism research and innovative therapy to prevent or reverse fibrosis.</p>-
dc.languageeng-
dc.publisherDe Gruyter-
dc.relation.ispartofMedical Review-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectbiliary fibrosis-
dc.subjectcholangiopathy-
dc.subjectetiology-
dc.subjectmechanism-
dc.subjecttherapeutic strategy-
dc.titleBiliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1515/mr-2024-0029-
dc.identifier.scopuseid_2-s2.0-85198110034-
dc.identifier.volume4-
dc.identifier.issue4-
dc.identifier.spage326-
dc.identifier.epage365-
dc.identifier.eissn2749-9642-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats